![](https://www.biospectrumasia.com/uploads/articles/1721821554363-24619.jpg)
Singapore's STCC enters imCORE Network to advance cancer research and therapeutics
Singapore Translational Cancer Consortium (STCC) aims to catalyze and boost R&D around Cancer Immuno Therapeutics (CIT) through imCORE Network, a global initiative Singapore Translational Cancer Consortium (STCC) enters into a new alliance with Roche…